3 ASX shares that everyone's underestimating right now

The party's over for the share market. So now's the time to be very selective about which stocks to buy, according to Alphinity's Elfreda Jonker.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

All the tailwinds that helped ASX shares the past couple of years are disappearing, so investors need to be careful which stocks they buy into.

That's the opinion of Alphinity client portfolio manager Elfreda Jonker, who said we've now entered the part of the cycle known as a "stock pickers' market".

"Over the last 12 months, the Australian equity market has been supported by a strong cyclical earnings recovery, unprecedented fiscal support and an extraordinarily high level of liquidity in the global financial system," she wrote on the Alphinity blog.

"These supporting factors are progressively being priced in, removed, or becoming more fragile."

In such an environment, Jonker presented 3 ASX shares that her team has "high conviction" faith in:

a woman sitting at a computer making an ok symbol with her hand, making a circle with her thumb and forefinger and holding the other three fingers up straight, as she sits in a colourful courtyard setting.

Image source: Getty Images

A global health problem has ironically resulted in less hospitalisations

According to Jonker, private health insurer Medibank Private Ltd (ASX: MPL) has become "the best manager of claim costs in the industry through the use of its scale and data".

Like most health insurers, it has benefitted from the COVID-19 pandemic resulting in lower rates of hospital treatments to pay out.

"The company has taken conservative provisions for COVID and is now giving back to customers via lower prices/free coverage days, cementing its recent brand improvement and return to customer number growth," said Jonker.

"Medibank has big plans to grow its in-home care and become a more holistic health business, which we believe is likely underappreciated over [the] long term."

She added that Medibank is "very well capitalised".

"[Medibank] is likely to put some gearing into the business, freeing up equity for capital management or acquisitions."

Medibank shares were trading at $3.59 on early Monday morning, which is more than 18% up for the year.

ASX share that benefits from both the pandemic and re-opening

Among retailers, the Alphinity team has high conviction for Super Retail Group Ltd (ASX: SUL).

Jonker reckons its brands like Supercheap Auto, BCF and Rebel Sport are both COVID beneficiaries and recovery winners.

"The company has managed its inventory well despite many supply chain challenges and is well placed for a reopening of the economy later in the year," she said. 

"Cost management has also been good, benefiting somewhat from lower rent with many landlords under pressure."

Super Retail's capital position is such that it's able to hand out a 7.4% dividend yield currently.

But according to Jonker, it's still holding onto plenty of excess cash to re-invest into the business.

"Its recently released FY21 results were ahead of market expectations and it has subsequently enjoyed earnings upgrades for FY22 and FY23," she said.

"We see scope for further upgrades over the course of the year as better trading conditions and a strong online strategy more than offset any reopening pressure."

Super Retail shares were trading at $12.06 on Monday morning, which is up 9.8% for the year.

Good to have control of your own prices

There are 3 factors driving the good fortunes behind construction materials provider James Hardie Industries plc (ASX: JHX).

"The company has been benefiting from the current environment of low interest rates, strong home prices and consumer working pattern shifts – all of which are supportive of large home repair/remodel projects," said Jonker.

"The company is uniquely positioned to capitalise on strong market conditions with new production capacity coming on at the same time competitors are capacity constrained."

She liked that James Hardie has shifted to a "value-led" strategy, allowing it to increase prices for its products.

"In addition, it is launching new products that will increase its total addressable market," said Jonker.

"Margins continue to surprise positively given both volume and pricing growth despite continued investment in future growth initiatives."

The potential risk to James Hardie is a rise in US interest rates killing off the housing boom in that country.

James Hardie stocks were going for $52.92 on Monday morning, which is a tidy 37.2% gain for the year thus far.

Motley Fool contributor Tony Yoo has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and has recommended Super Retail Group Limited. The Motley Fool Australia owns shares of and has recommended Super Retail Group Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

A man looking at his laptop and thinking.
Broker Notes

Buy, hold, sell: What this leading broker is saying about Lynas shares

Is it bullish or bearish? Let's find out.

Read more »

share buyers, investors, happy investors
Broker Notes

Bell Potter's top ASX 200 holdings revealed

These are the top holdings in the broker's core portfolio.

Read more »

An athlete runs fast with a trail of yellow smoke billowing out behind him.
Broker Notes

Up 139% in a year, why this buy rated ASX All Ords rare earths stock could keep racing higher

A leading broker forecasts more outperformance to come from this surging ASX rare earths stock.

Read more »

Miner with thumbs up at a mine.
Gold

2 ASX gold miners to buy for solid share price gains, according to Barrenjoey

The Africa-focused companies are deeply undervalued after recent sell-offs, the broker says.

Read more »

A male sharemarket analyst sits at his desk looking intently at his laptop with two other monitors next to him showing stock price movements
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

A happy family of four on holidays stand on a jetty and cheer.
Broker Notes

Down 40% in 2026, should you buy the big dip in Life360 shares?

A leading analyst offers his outlook for Life360 shares.

Read more »

Buy and sell on yellow paper with pins on them and several share price lines.
Broker Notes

Sell alert! Why this expert is calling time on Nuix and Brainchip shares

A leading analyst forecasts more pain to come for Brainchip and Nuix shares. But why?

Read more »

a man lies on his back on grass with his eyes shut and a contented look on his face as though he is dreaming
Broker Notes

With global populations ageing, are ResMed shares a good buy today?

A leading expert delivers his verdict on the outlook for ResMed shares.

Read more »